Key Players
- Autolus Therapeutics plc
- Cellares Corporation
- Bayer
- BioNTech SE
- Biomanufacturing Capacity Owners
- Bioproduction platforms
- Biotech incubators
- Bristol-Myers Squibb
- CARsgen Therapeutics
- CO.DON
- Cell
- Cellares Japan
- Cellectis S.A
- Commercial GMP CDMOs
- Cytiva India
- T. Rowe Price
- Domestic CAR-T sponsors
- ElevateBio
- European ATMP partners
- Fujifilm Holdings
- Fosun Kite
- Gene Therapy Catapult
- Healios
- Hrain Biotechnology
- IASO Bio
- Immuneel Therapeutics
- ImmunoACT
- Lonza Group
- JW Therapeutics
- Juventas Cell Therapy Ltd
- Kite Pharma Inc
- Legend Biotech
- Local CDMO partners
- Local GMP CDMOs
- Lonza
- Manufacturing Channels
- Mesoblast Ltd
- Miltenyi Biotec
- Minaris Advanced Therapies
- Mitsui Fudosan
- Mnemo Therapeutics
- Nikon CeLL innovation
- OmniaBio Inc
- Oncology networks
- Oxford Biomedica plc
- Pandorum Technologies Pvt. Ltd
- Danaher Corporation
- ProBioGen AG
- Quell Therapeutics
- RACTHERA
- RHEACELL / TICEBA
- Regrow Biosciences Pvt. Ltd
- Resolution Therapeutics
- RoslinCT
- Sales
- Sartorius Stedim Biotech S.A
- Specialist ATMP CDMOs
- Specialist CDMO networks
- Specialist Cell Therapy CDMOs
- Sumitomo Pharma Co. Ltd
- Thermo Fisher Scientific Inc.
- TreeFrog Therapeutics
- UK ATMP manufacturers
- Viral vector CDMOs
- YposKesi
